Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2019073 | 0.69 | — | — | |
| SCHEMBL7059019 | 0.68 | CES1 (0.35) | — | |
| SCHEMBL613060 | 0.67 | GABRA1 (0.44) | ALDH1A1GAA | |
| SCHEMBL11498457 | 0.67 | NISCH (0.35) | — | |
| SCHEMBL2464690 | 0.65 | — | — | |
| SCHEMBL6626771 | 0.63 | — | — | |
| SCHEMBL10373736 | 0.63 | GABRA1 (0.30) | — | |
| SCHEMBL11412815 | 0.62 | AHR (0.49) | MEN1KMT2ATSHRLMNACYP1A2 | |
| SCHEMBL31125018 | 0.62 | NPC1 (0.44) | ALDH1A1HPGD | |
| SCHEMBL7089809 | 0.62 | GABRA1 (0.60) | ALDH1A1HPGDMEN1KMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1740156-B8 | METHOD FOR THE PRODUCTION OF AN ABUSE-PROOF, SOLID FORM OF ADMINISTRATION | GRUENENTHAL GMBH (DE) | 2012-07-11 | — | — | EP | disclosed |
| EP-2131830-A2 | PHARMACEUTICAL FORM WITH IMPEDED ABUSE | Grünenthal GmbH (DE) | 2009-12-16 | — | — | EP | disclosed |
| EP-1996172-A1 | PLASTER PACKAGING | Grünenthal GmbH (DE) | 2008-12-03 | — | — | EP | disclosed |
| EP-1996171-A1 | EASY-TO-HANDLE PLASTER CONTAINING AN ACTIVE SUBSTANCE | Grünenthal GmbH (DE) | 2008-12-03 | — | — | EP | disclosed |
| WO-2008107149-A2 | PHARMACEUTICAL FORM WITH IMPEDED ABUSE | Grünenthal GmbH (DE) | 2008-09-12 | — | — | WO | disclosed |
| EP-1928436-A2 | APPLICATION SYSTEM FOR A PLASTER CONTAINING AN ACTIVE INGREDIENT AND A CONTROLLED-RELEASE AGENT FOR SAID ACTIVE INGREDIENT | Grünenthal GmbH (DE) | 2008-06-11 | — | — | EP | disclosed |
| EP-1845956-A1 | BREAK-RESISTANT DELAYED-RELEASE FORMS OF ADMINISTRATION | Grünenthal GmbH (DE) | 2007-10-24 | — | — | EP | disclosed |
| EP-1845955-A1 | METHOD FOR THE PRODUCTION OF A TAMPER-PROOF FORM OF ADMINISTRATION | Grünenthal GmbH (DE) | 2007-10-24 | — | — | EP | disclosed |
| WO-2007101659-A1 | EASY-TO-HANDLE PLASTER CONTAINING AN ACTIVE SUBSTANCE | Grünenthal GmbH (DE) | 2007-09-13 | — | — | WO | disclosed |
| WO-2007101660-A1 | PLASTER PACKAGING | Grünenthal GmbH (DE) | 2007-09-13 | — | — | WO | disclosed |
| WO-2005102294-A2 | TRANSDERMAL SYSTEM SECURED AGAINST MISUSE | Grünenthal GmbH (DE) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005102270-A2 | AGENT-RELEASING SYSTEM COMPRISING AN AGENT-CONTAINING PATCH AND AT LEAST ONE MEANS REGULATING THE RELEASE OF AGENTS | Grünenthal GmbH (DE) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005102286-A1 | METHOD FOR THE PRODUCTION OF AN ABUSE-PROOF, SOLID FORM OF ADMINISTRATION | Grünenthal GmbH (DE) | 2005-11-03 | — | — | WO | disclosed |
| EP-1558257-A1 | DOSAGE FORM THAT IS SAFEGUARDED FROM ABUSE | Grünenthal GmbH (DE) | 2005-08-03 | — | — | EP | disclosed |
| WO-2005063214-A1 | METHOD FOR THE PRODUCTION OF AN ADMINISTRATION FORM WHICH IS SECURED AGAINST MISUSE | Grünenthal GmbH (DE) | 2005-07-14 | — | — | WO | disclosed |
| EP-1515702-A1 | ABUSE-PROTECTED ADMINISTRATION FORM | Grünenthal GmbH (DE) | 2005-03-23 | — | — | EP | disclosed |
| WO-2005016313-A1 | DOSAGE FORM THAT IS SAFEGUARDED FROM ABUSE | Grünenthal GmbH (DE) | 2005-02-24 | — | — | WO | disclosed |
| WO-2005016314-A1 | FORM OF ADMINISTRATION SECURED AGAINST MISUSE | Grünenthal GmbH (DE) | 2005-02-24 | — | — | WO | disclosed |
| WO-2004037259-A1 | DOSAGE FORM THAT IS SAFEGUARDED FROM ABUSE | Grünenthal GmbH (DE) | 2004-05-06 | — | — | WO | disclosed |
| WO-2003105808-A1 | ABUSE-PROTECTED ADMINISTRATION FORM | Grünenthal GmbH (DE) | 2003-12-24 | — | — | WO | disclosed |